facebook


Go ProSubmit a deal
Submit
Series CIsomorphic Labs

Isomorphic Labs Raises $5 Billion In Series C Funding Round Co-Led By Greenoaks And Sequoia Capital

Isomorphic Labs, a London-based AI drug discovery company founded and led by CEO Sir Demis Hassabis, raised $5 billion in a Series C funding round co-led by Greenoaks and Sequoia Capital , with participation from Andr…

By TradedVC Editorial1 min read

Isomorphic Labs, a London-based AI drug discovery company founded and led by CEO Sir Demis Hassabis, raised $5 billion in a Series C funding round co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz (a16z), Alphabet and existing investors Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund. The company will use the funding to advance its AI-powered drug design engine, scale its therapeutic candidate pipeline, expand its foundational simulation models and build global infrastructure for AI-led bioengineering as it moves its first drug candidates toward clinical trials.

FOUNDER: Sir Demis Hassabi

INVESTORS: Greenoaks, Sequoia Capital, Andreessen Horowitz (a16z), Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek, UK Sovereign AI Fund

ROUND: Series C AMOUNT: $5,000,000,000

HQ: London, United Kingdom

#VentureCapital #IsomorphicLabs #SirDemisHassabi #TradedVC

ABOUT THE DEAL

Raise
$5B
Round
Series C
Company
Isomorphic Labs
Desk
Deals
Filed
Nov 17, 2026
Founders
  • Sir Demis Hassabi
Investors
ALL DEALS
Deal

Isomorphic Labs Raises $5 Billion In Series C Funding Round Co-Led By Greenoaks And Sequoia Capital

Nov 17, 2026

Deal

Zya Secures £11.5 Million In Series A Funding For Food Technology Development

Nov 17, 2026

Deal

Plural Secures €1 Billion In Its Largest Fundraise To Date

Nov 17, 2026